David A. Sneider Partner

David A. Sneider is a Partner at Simpson Thacher & Bartlett LLP PRACTICE FOCUS in the Firm’s Corporate Department. David advises both Japanese and multinational clients in cross-border transactions Corporate involving Japan, with a focus on mergers and acquisitions and Capital Markets capital markets transactions. His clients include many of the Corporate Governance leading Japanese and U.S. financial institutions in Tokyo. Mergers and Acquisitions Corporate – M&A David has been ranked as one of the leading U.S. corporate Debt finance lawyers in transactions related to Japan in a number of Initial Public Offerings recent surveys, including Legal Media Group’s The Best of the INDUSTRIES Best, International Financial Law Review’s Guide to the World’s Leading M&A Lawyers, Euromoney’s Guide to the World’s Healthcare Leading Capital Markets Lawyers, Legal 500 Asia Pacific, Asia Law’s Guide to Asia’s Leading Lawyers and Global Counsel 3000. He was named International Dealmaker of the Year for Japan by Asia Legal Business in 2005 and 2006. Chambers Guide to the World’s Leading Lawyers included David among its “Global 100” Lawyers in 2000. He was also appointed to Japanese Government Study Group in reviewing fair M&A procedures in Japan in 2018.

David was appointed in 2014 as a Commissioner of the Japan- United States Friendship Commission, an independent U.S. federal agency established by Congress in 1975 to strengthen the U.S.-Japan relationship through educational, cultural and intellectual exchange.

www.simpsonthacher.com 1 David joined Simpson Thacher in 1992 and became a Partner in 1994. He received his B.A., summa cum laude, from Yale University in 1979, where he was elected Phi Beta Kappa, and his J.D., cum laude, from Harvard Law School in 1984. He also studied at Tokyo University from 1979 to 1980.

David’s recent representative M&A transactions include representing:

KKR in its sale of Kokusai Electric to Applied Materials KKR’s acquisitions of Calsonic Kansei, Hitachi Kokusai Electric and Hitachi Koki KKR in its acquisition of Panasonic Healthcare for approximately ¥165 billion (US$1.67 billion) and Panasonic Healthcare's subsequent acquisition of the diabetes care business of Bayer Calsonic Kansei (wholly owned portfolio company by KKR) in its acquisition of Magneti Marelli for US$7.1 billion

David’s experience in global IPOs by Japanese issuers includes representing:

Underwriters in Japan Airlines ¥663 billion (approximately US$8.5 billion) IPO on the Tokyo Stock Exchange and global offering, the second largest IPO globally in 2012 Sony Financial Holdings in its ¥320 billion IPO on the Tokyo Stock Exchange and global offering Universal Studios Japan in its ¥28 billion IPO and listing on the Tokyo Stock Exchange and global offering SUMCO Corporation in its ¥144 billion IPO and listing on the Tokyo Stock Exchange and global offering Elpida Memory, Inc. in its ¥102 billion IPO on the Tokyo Stock Exchange and Reg S/Rule 144A offering of common stock Daido Life Insurance in its ¥161.5 billion IPO on the Tokyo Stock Exchange and global offering Underwriters led by Nomura Securities and UBS Limited in the ¥375 billion IPO on the Tokyo Stock Exchange and global offering by Electric Power Development Co., Ltd. (J- Power) Underwriters led by Daiwa Securities SMBC, Goldman

www.simpsonthacher.com 2 Sachs, Nikko Citigroup and Nomura Securities in the ¥160 billion IPO on the Tokyo Stock Exchange and global offering by INPEX Corporation